19F NMR Studies of Plasminogen Activator Inhibitor-1
Authors:
- Grant E. BlouseGBGrant E. Blouse
- Michel J. PerronMPMichel J. Perron
- Joseph D. ShoreJSJoseph D. Shore
- Linda A. LuckLLLinda A. Luck
- Arthur G. SzaboASArthur G. Szabo
- 24 January 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 43 (6) , 1507-1519
Abstract
Plasminogen activator inhibitor-1 (PAI-1) is a 43 kDa protein involved in the regulation of fibrinolysis. PAI-1 is the principal inhibitor of tissue-type plasminogen activator (t-PA), trapping the proteinase as an acyl-enzyme covalent complex (∼105 kDa). Four single tryptophan mutants of PAI-1 have been constructed in which three of the four tryptophan residues (Trp86, Trp139, Trp175, and Trp262) were replaced with phenylalanine. Biosynthetic incorporation of 5-fluorotryptophan (5F-Trp) into wild-type PAI-1 (5FW wtPAI-1) and the single tryptophan mutants (5FW86, 5FW139, 5FW175, and 5FW262) was achieved, allowing a 19F NMR spectroscopic study of PAI-1 in its active and cleaved forms and in complex with t-PA. The 19F NMR spectrum of active 5FW wtPAI-1 shows four clearly resolved peaks at −39.20, −49.26, −50.74, and −52.57 ppm relative to trifluoroacetic acid at 0 ppm. Unequivocal assignments of these four resonances in the spectrum of 5FW wtPAI-1 to specific tryptophan residues were accomplished by measuring the chemical shifts of the 19F resonances of the single tryptophan mutants. There was close agreement between the resonances observed in 5FW wtPAI-1 and of those in the mutants for all three protein forms. This would imply little structural perturbation in the local structures of the tryptophan residues resulting from substitution by phenylalanine. The 5FW wtPAI-1 was observed to have lower second-order rate constant (kapp) for the inhibition of t-PA than the natural tryptophan wtPAI-1, suggesting that the decreased activity may result from a small structural effect of the fluorine substituent of the indole ring. Further alterations in the kapp and the stoichiometry of inhibition (SI) were observed in each of the mutants indicating an effect of the three tryptophan to phenylalanine mutations. Detailed interpretation of the 19F NMR spectra of the PAI-1 mutants provides insights into the local segmental structure of the active form of the proteins and the structural changes that occur in the cleaved and t-PA complexed forms.Keywords
This publication has 22 references indexed in Scilit:
- The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse ProteinsJournal of Biological Chemistry, 2001
- Conformational changes in serpins: I. the native and cleaved conformations of α 1 -antitrypsin 1 1Edited by J. M. ThorntonJournal of Molecular Biology, 2000
- Mapping the Serpin-Proteinase Complex Using Single Cysteine Variants of α1-Proteinase Inhibitor PittsburghJournal of Biological Chemistry, 1998
- A Spectroscopic Study of the Structures of Latent, Active and Reactive‐Center‐Cleaved Type‐1 Plasminogen‐Activator InhibitorEuropean Journal of Biochemistry, 1996
- Use of 19F NMR to Probe Protein Structure and Conformational ChangesAnnual Review of Biophysics, 1996
- Serpin-Protease Complexes Are Trapped as Stable Acyl-Enzyme IntermediatesJournal of Biological Chemistry, 1995
- Dynamic structural and functional relationships in recombinant plasminogen activator inhibitor-1 (rPAI-1)Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1993
- Secondary structure changes stabilize the reactive-centre cleaved form of SERPINs: A study by 1H nuclear magnetic resonance and Fourier transform infrared spectroscopyJournal of Molecular Biology, 1992
- cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.Journal of Clinical Investigation, 1986
- A new acid hydrolysis method for determining tryptophan in peptides and proteinsAnalytical Biochemistry, 1974